Pneumococcal infections and sickle cell disease in Africa: Does absence of evidence imply evidence of absence?

Archives of Disease in Childhood

Volumn 94, Issue 9, 2009, Pages 713-716

  Obaro, S ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLIN G; PNEUMOCOCCUS VACCINE;

AFRICA; BACTEREMIA; CHILD; CHILDHOOD MORTALITY; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HUMAN; MALARIA; MULTICENTER STUDY; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; REVIEW; SALMONELLOSIS; SICKLE CELL ANEMIA; STRUCTURED QUESTIONNAIRE;

AFRICA SOUTH OF THE SAHARA; ANEMIA, SICKLE CELL; ANIMALS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; DEVELOPING COUNTRIES; DISEASE SUSCEPTIBILITY; HUMANS; INFANT; MALARIA; PLASMODIUM FALCIPARUM; PNEUMOCOCCAL INFECTIONS; PREVALENCE;

EID: 69249139592     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2008.154815     Document Type: Review

References (43)

1. Ingram VM. Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature 1957;180:326-328
2. Kizito E, Mworozi E, Ndugwa C, et al. Bacteraemia in homozygous sickle cell disease in Africa: is pneumococcal prophylaxis justified? Arch Dis Child 2007;92:21-23
3. Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year? Lancet 2003;361:2226-2234
4. Lehman H, Raper AB. Distribution of the sickle-cell trait in Uganda and its ethnological significance. Nature 1949;164:494-495
5. Serjeant GR, Ndugwa CM. Sickle cell disease in Uganda: a time for action. East Afr Med J 2003;80:384-387 (Pubitemid 41289248)
6. World Health Organization. Sickle-cell anaemia. Report by the Secretariat. http:// www.who.int/gb/ebwha/pdf-files/WHA59/A59-9-en.pdf (accessed 24 May 2009).
7. Wierenga KJJ, Hambleton LR, Lewis NA. Survival estimates for patients with homozygous sickle-cell disease in Jamaica; a clinic-based population study. Lancet 2001;357:680-683
8. Fleming AF. The presentation, management and prevention of crisis in sickle cell disease in Africa. Blood Rev 1989;3:18-28. (Pubitemid 19086222)
9. Embury SH, Hebbel R, Mohandas N, et al. Sickle cell disease: Basic principles and clinical practice. New York: Raven Press, 1994.
10. Moore CM, Ehlayel M, Leiva LE, et al. New concepts in the immunology of sickle cell disease. Ann Allergy Asthma Immunol 1996;76:385-400. (Pubitemid 26153148)
11. Johnson RB Jr, Newman SL, Smith AG. An abnormality of the alternate pathway of complement activation in sickle cell-disease. New Engl J Med 1973;288:803-808
12. Bjornson AB, Gatson MH, Zellner CL. Decreased opsonization for Streptococcus pneumoniae in sickle cell disease: studies on selected complement components and immunoglobulins. J Pediatr 1977;91:371-378
13. De Ceulaer K, Wilson WA, Morgan AG, et al. Plasma haemoglobin and complement activation in sickle cell disease. J Clin Lab Immunol 1981;6:57-60. (Pubitemid 11072050)
14. Akinyanju OO. In vivo neutrohpil migration and nitroblue tetrazolium reduction in sickle cell disease. Clin Lab Haematol 1985;7:133-142
15. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. New Engl J Med 1986;314:1593.
16. Kotoney-Ahulu FID. Malaria and sickle cell disease. BMJ 1971;2:710-711
17. Ashley-Koch, Young Q, Olney RS. Sickle haemoglobin (HbS) allele and sickle cell disease: a HuGE review. Am J Epidemiol 2000;151:839-845 (Pubitemid 30461125)
18. Alouch JR. Higher incidence of Plasmodium falciparum infection in patients with homozygous sickle cell disease in western Kenya. Trop Med Int Health 1997;2:568-571
19. Maharajan R, Flemming AF, Egler L. Pattern of infections among patients with sickle cell anaemia requiring hospital admission. Nig J Paed 1983;10:13-17.
20. Konotney-Ahulu FID. Treatment and prevention of sickle cell crisis. Lancet 1971;2:1255.
21. Collbourne MJ, Edington GM. Sickling and malaria in the Gold Coast. BMJ 1956;1:785-786
22. Molineaux L, Flemming AF, Cornille-Brogger R, et al. Abnormal haemoglobins in the Sudan savanna of Nigeria. III. Malaria, immunoglobulins and antimalarial antibodies in sickle cell disease. Ann Trop Med Parasitol 1979;73:301-310
23. Adeloye A, Luzzatto L, Edington GM. Severe malarial infection in a patient with sickle cell anaemia. BMJ 1971;2:445-446
24. Oniyangi O, Omari AA. Malaria chemoprophylaxis in sickle cell disease. Cochrane Database Syst Rev 2003;(3):CD003489.
25. Barrett-Connor E. Bacterial infection and sickle cell anemia. Medicine 1971;50:97-112.
26. Serjeant GR. Mortality from sickle cell disease in Africa. BMJ 2005;330:432-433 (Pubitemid 40314205)
27. Graham SM, Walsh AL, Molyneux EM, et al. Clinical presentation of non-typhoidal Salmonella bacteraemia in Malawian children. Trans R Soc Trop Med Hyg 2000;94:310-314 (Pubitemid 30406567)
28. Brent AJ, Ahmed I, Ndiritu M, et al. Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based observational study. Lancet 2006;367:482-488 (Pubitemid 43208904)
29. Akuse RM. Variation in the pattern of bacterial infection in patients with sickle cell disease requiring admission. J Trop Pediatr 1996;42:318-323
30. Okuonghae HO, Nwankwo MU, Offor EC. Pattern of bacteremia in febrile children with sickle cell anemia. Ann Trop Pediatr 1993;13:55-64. (Pubitemid 23092333)
31. Akinyanju O, Johnson AO. Acute illness in Nigerian children with sickle cell anemia. Ann Trop Paediatr 1987;7:181-186
32. Aken'ova YA, Bakare RA, Okunade MA. Septicaemia in sickle cell anaemia patients: the Ibadan experience. Cent Afri J Med 1998;44:102-104
33. Berkley JA, Lowe BS, Mwangi I, et al. Bacteremia among children admitted to a rural hospital in Kenya. New Engl J Med 2005;352:39-47. (Pubitemid 40075679)
34. Cutts FT, Zaman SM, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005;365:1139-1146 (Pubitemid 40417563)
35. Enwere G, Biney E, Cheung YB, et al. Epidemiologic and clinical characteristics of community-acquired invasive bacterial infections in children aged 2-29 months in The Gambia. Pediatr Infect Dis J 2006;25:700-705 (Pubitemid 44162127)
36. Campbell JD, Kotloff KL, Sow SO, et al. Invasive pneumococcal infections among hospitalized children in Bamako, Mali. Pediatr Infect Dis J 2004;23:642-649 (Pubitemid 38924889)
37. Blomberg B, Manji KP, Urassa WK, et al. Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort study. BMC Infect Dis 2007;7:43. (Pubitemid 46939457)
38. Roca A, Quintó L, Abacassamo F, et al. Invasive Haemophilus influenzae disease in children less than 5 years of age in Manhiça, a rural area of southern Mozambique. Trop Med Int Health 2008;13:818-826 (Pubitemid 351678631)
39. Bercion R, Bobossi-Serengbe G, Gody JC, et al. Acute bacterial meningitis at the "Complexe Pédiatrique" of Bangui, Central African Republic. J Trop Pediatr 2008;54:125-128
40. Holliman RE, Liddy H, Johnson JD, et al. Epidemiology of invasive pneumococcal disease in Kumasi, Ghana. Trans R Soc Trop Med 2007;101:405-413 (Pubitemid 46196264)
41. Hailu M, Muhe L. Childhood meningitis in a tertiary hospital in Addis Ababa: clinical and epidemiological features. Ethiop Med J 2001;39:29
42. Aidoo M, Terlouw DJ, Kolczak MS, et al. Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet 2002;359:1311-1312 (Pubitemid 34310639)
43. Athale UH, Chintu C. Clinical analysis of mortality in hospitalized Zambia children with sickle cell anaemia. Afr Med J 1994;91:388-391